World Pharma Today

CordenPharma Seals AmbioPharm Deal to Expand Global Network

Yuvraj — Sat, 30 May 2026 08:25:37 +0000

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm Deal strengthens the company’s manufacturing presence in the United States while adding newly integrated production capabilities in Shanghai, China. The move allows CordenPharma to comprehensively support the growing global demand for […]

The post CordenPharma Seals AmbioPharm Deal to Expand Global Network first appeared on World Pharma Today.

Shilpa Biologicals Urges Stronger CDMO Selection Strategy

Yuvraj — Sat, 30 May 2026 07:52:22 +0000

Ahead of BIO San Diego next month, Shilpa Biologicals has called on emerging biotech companies to rethink how they approach CDMO Selection as investment conditions begin to improve across the biopharma sector. Madhav Bhutada, Director of Shilpa Biologicals, said many innovators developing increasingly sophisticated therapies, including bispecific and trispecific antibodies, continue to depend on a […]

The post Shilpa Biologicals Urges Stronger CDMO Selection Strategy first appeared on World Pharma Today.

The Push for Greater Accuracy in Clinical Trials

Yuvraj — Sat, 30 May 2026 06:44:59 +0000

Clinical trials are the foundation of modern medicine. Every treatment, therapy, and medical breakthrough relies on accurate research to ensure safety and effectiveness. However, maintaining accuracy across complex studies has always been a challenge. With large patient populations, multiple trial sites, and increasing volumes of data, research teams must work harder than ever to minimize […]

The post The Push for Greater Accuracy in Clinical Trials first appeared on World Pharma Today.

The Four Principles of Medicines Optimisation in Primary Care

Yuvraj — Sat, 30 May 2026 06:42:39 +0000

Medicines optimisation in primary care became a formal discipline in 2013, when the Royal Pharmaceutical Society set out a four-principle framework that has guided the work ever since. The language was new at the time, but the underlying ideas were not. The framework redirected clinical attention from the medicine to the patient taking it and […]

The post The Four Principles of Medicines Optimisation in Primary Care first appeared on World Pharma Today.

MSD and Adcendo Initiate Phase Ib Collaboration for Solid Tumours

Yuvraj — Fri, 29 May 2026 13:23:20 +0000

MSD and Adcendo have established a collaboration and supply agreement to evaluate the combination of ADCE-T02 and pembrolizumab. The companies are preparing for a Phase Ib solid tumour clinical trial targeting patients with advanced solid tumours. Adcendo will act as the sponsor for the solid tumour clinical trial, with MSD providing pembrolizumab. ADCE-T02 is an […]

The post MSD and Adcendo Initiate Phase Ib Collaboration for Solid Tumours first appeared on World Pharma Today.

Chemspec Europe 2026 Draws Global Industry Participation

Yuvraj — Fri, 29 May 2026 11:05:12 +0000

Chemspec Europe returned to Cologne on 6–7 May 2026, bringing together professionals from across the speciality chemicals sector despite ongoing economic and regulatory challenges facing the industry. The event welcomed 4,238 attendees representing 60 nations and featured 454 exhibitors from 28 countries, marking growth compared with the previous edition. Participants represented a broad range of […]

The post Chemspec Europe 2026 Draws Global Industry Participation first appeared on World Pharma Today.

SK Bioscience Inks Colombia Vaccine Localization Deal

Yuvraj — Wed, 27 May 2026 06:14:15 +0000

In a critical step for Colombia vaccine localization, SK Bioscience will execute a vaccine technology transfer with Colombia’s state-owned pharmaceutical enterprise, VECOL. The partnership focuses on building a local manufacturing site to align with the country’s national vaccine localization initiative. The agreement supports a broader state initiative jointly led by VECOL, the Colombian Ministry of […]

The post SK Bioscience Inks Colombia Vaccine Localization Deal first appeared on World Pharma Today.

Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy

Yuvraj — Wed, 27 May 2026 05:29:27 +0000

After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than $3.8 billion. This infectious disease M&A activity secures Curevo, LimmaTech Biologics, and Vaccine Company, firmly positioning the pharmaceutical organization within the vaccine development arena. The transactions represent a deliberate return to […]

The post Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy first appeared on World Pharma Today.

Colorimeters Enhancing Consistency in Pharma Testing

Yuvraj — Tue, 26 May 2026 07:03:00 +0000

Maintaining absolute uniformity across multiple production cycles is a fundamental and complex challenge in the pharmaceutical industry. The strategic application of colorimeters pharma testing allows for the precise quantification of hue and saturation, providing a reliable and objective metric for assessing raw material quality and final product stability. These specialized instruments simplify the inherent complexity of color analysis, enabling laboratory technicians to identify subtle variations that might otherwise compromise the efficacy or consumer acceptance of a medicinal product. By establishing a digital standard for appearance, manufacturers ensure that every batch meets the most rigorous quality expectations.

The post Colorimeters Enhancing Consistency in Pharma Testing first appeared on World Pharma Today.

Advanced Color Measurement Strengthening Pharma QC

Yuvraj — Tue, 26 May 2026 07:00:49 +0000

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.

The post Advanced Color Measurement Strengthening Pharma QC first appeared on World Pharma Today.